Medical uses:
Sotyktu (deucravacitinib) is a tyrosine kinase 2 (TYK2) inhibitor indicated for the treatment of adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy.
Limitations of Use: Sotyktu should not be used in combination with other potent immunosuppressants.
Recommended Dosage:
- Pre-Treatment Evaluation: Screen patients for active and latent tuberculosis (TB) infection before starting Sotyktu. If TB is detected, begin appropriate treatment for TB before initiating Sotyktu. Ensure immunizations are up-to-date according to current guidelines.
- Dosage: The recommended dose is 6 mg taken orally once daily, with or without food. Do not chew, crush, or split the tablets.
- Hepatic Impairment: Sotyktu is not recommended for patients with severe hepatic impairment (Child-Pugh Class C).
Warnings & Precautions:
Hypersensitivity Reactions: Patients receiving Sotyktu may experience hypersensitivity reactions such as angioedema. If a significant hypersensitivity reaction occurs, appropriate therapy should be initiated, and Sotyktu should be discontinued.
Infection Risk: Sotyktu can increase the risk of infections. It should not be used in patients with active or severe infections. Patients should be closely monitored for signs and symptoms of infection during and after treatment with Sotyktu.
Tuberculosis Considerations: For patients with a history of latent or active tuberculosis (TB) where an adequate course of treatment cannot be confirmed, consider anti-TB therapy before starting Sotyktu 6 mg tablets. Monitor these patients for signs and symptoms of active TB throughout the treatment.
Malignancy Risk: Malignancies, including lymphomas, may occur with Deucravacitinib. Weigh the benefits and risks for each patient before starting or continuing treatment, especially in those with a known malignancy or those who develop a malignancy while on Deucravacitinib.
Immunizations: Ensure all age-appropriate immunizations are up-to-date according to current guidelines before initiating treatment with Deucravacitinib, including prophylactic herpes zoster vaccination. Live vaccines should not be used in patients treated with this medication. The response to live or non-live vaccines has yet to be assessed.
Documentation & Availability :
Documents required to import SOTYKTU to India?
SOTYKTU (deucravacitinib) tablets can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- 2 ID proofs along with PAN card details along with attested scanned copies
- Valid doctor prescription scanned copy
- Doctor’s MCI number
- Doctor’s mobile number
- Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- The above-mentioned documents and drug availability.
- Import permit if applicable.
Sourcing & Delivery:
The Rx4U team has extensive experience in sourcing SOTYKTU (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ:
What is the generic name for the trade name drug Sotyktu®?
The generic name for Sotyktu® is deucravacitinib.
Who manufactures Sotyktu®?
Sotyktu® is manufactured by Bristol Myers Squibb.
Is Sotyktu® approved by the FDA?
Yes, Sotyktu® received FDA approval on September 9, 2022.
Where can I find the best price for Sotyktu® in India?
For the best price on Sotyktu® in India, contact Rx4u team.
What is the dosage and form of Sotyktu®?
Sotyktu® is available as 6 mg tablets for oral administration.
What are the most common side effects of Sotyktu®?
Common side effects include increased blood creatine phosphokinase, acne, herpes simplex, upper respiratory infections, folliculitis, and mouth ulcers.
How much does Sotyktu® cost in India?
The price of Sotyktu® in India can vary. To purchase this TYK2 inhibitor legally, you can reach out to Rx4u team.
What are the storage conditions for Sotyktu®?
Store Sotyktu® tablets at room temperature, between 68 to 77°F (20 to 25°C).
Is it safe to buy Sotyktu® online in India?
Yes, you can safely purchase Sotyktu® online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
